Orthofix Medical Inc.
OFIX
$14.51
$0.010.07%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.27% | 2.67% | 7.61% | 6.85% | 6.20% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.27% | 2.67% | 7.61% | 6.85% | 6.20% |
| Cost of Revenue | -0.44% | 17.37% | 12.37% | -4.19% | -5.33% |
| Gross Profit | 3.55% | -4.42% | 5.72% | 12.77% | 12.71% |
| SG&A Expenses | 1.70% | 0.98% | 3.17% | 6.60% | 0.59% |
| Depreciation & Amortization | -10.33% | -53.73% | 0.49% | 4.14% | -6.80% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.26% | 3.97% | 5.23% | 2.05% | -2.00% |
| Operating Income | 23.22% | -11.99% | 34.83% | 32.95% | 42.43% |
| Income Before Tax | 56.05% | -48.24% | -34.75% | 6.16% | 14.66% |
| Income Tax Expenses | -113.10% | 12.93% | -551.20% | 59.11% | -28.12% |
| Earnings from Continuing Operations | 57.90% | -47.40% | -31.44% | 5.09% | 15.18% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 57.90% | -47.40% | -31.44% | 5.09% | 15.18% |
| EBIT | 23.22% | -11.99% | 34.83% | 32.95% | 42.43% |
| EBITDA | 119.55% | 110.70% | 284.62% | 98.71% | 72.60% |
| EPS Basic | 59.47% | -41.96% | -26.68% | 8.15% | 17.99% |
| Normalized Basic EPS | 50.76% | 0.81% | -74.88% | 18.19% | 27.79% |
| EPS Diluted | 59.09% | -41.96% | -26.68% | 8.15% | 17.95% |
| Normalized Diluted EPS | 50.76% | 0.81% | -74.88% | 18.19% | 27.79% |
| Average Basic Shares Outstanding | 3.90% | 3.83% | 3.75% | 3.33% | 3.42% |
| Average Diluted Shares Outstanding | 3.90% | 3.83% | 3.75% | 3.33% | 3.42% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |